Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma
Author:
Publisher
BMJ
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1186/s40425-018-0375-1.pdf
Reference38 articles.
1. Dardano A, Penno G, Prato SD, Miccoli R. Optimal therapy of type 2 diabetes: a controversial challenge. Aging. 2014;6(3):187–206. https://doi.org/10.18632/aging.100646 .
2. Rang HP. Pharmacology. 5th ed. New York: Churchill Livingstone; 2003. p. 388.
3. Zhou G, Myers R, Li Y, et al. Role of AMP activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167–74.
4. Mu J, Brozinick JT, Valladares O, et al. A role for AMP-activated protein kinase in con- traction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell. 2001;7:1085–94.
5. Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002;277:25226–32.
Cited by 125 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act;Cancer Treatment Reviews;2024-09
2. Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment;Frontiers in Cell and Developmental Biology;2024-08-30
3. Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study;Cancer Immunology, Immunotherapy;2024-06-08
4. Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors;International Immunopharmacology;2024-06
5. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect;Translational Oncology;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3